AKT1 and neoplasm: Irrespective of the activation source, phosphorylated ErbB3 strongly couples to the PI3K/AKT pathway by means of six p85-binding sites and elicits a potent anti-apoptotic signal that drives tumor growth and survival [2,12,13].